In vitro effects of interleukin (IL)-1 beta inhibition on the epithelial-to-mesenchymal transition (EMT) of renal tubular and hepatic stellate cells
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In vitro effects of interleukin (IL)-1 beta inhibition on the epithelial-to-mesenchymal transition (EMT) of renal tubular and hepatic stellate cells
Authors
Keywords
Epithelial to mesenchymal transition, Canakinumab, Fibrosis, Liver, Kidney, Interleukin 1 beta
Journal
Journal of Translational Medicine
Volume 17, Issue 1, Pages -
Publisher
Springer Nature
Online
2019-01-08
DOI
10.1186/s12967-019-1770-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- IL-1 Inhibition in Systemic Juvenile Idiopathic Arthritis
- (2016) Gabriella Giancane et al. Frontiers in Pharmacology
- Systemic autoimmune disease in asbestosis rapidly responding to anti-interleukin-1beta antibody canakinumab: a case report
- (2015) Laura Niccoli et al. BMC MUSCULOSKELETAL DISORDERS
- Proteolytic Processing of Interleukin-1 Family Cytokines: Variations on a Common Theme
- (2015) Inna S. Afonina et al. IMMUNITY
- Canakinumab for the treatment of chronic obstructive pulmonary disease
- (2015) Paola Rogliani et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice
- (2013) Jean-Philippe Pradere et al. HEPATOLOGY
- The secretion of IL-1β and options for release
- (2013) Patrizia Piccioli et al. SEMINARS IN IMMUNOLOGY
- The Central Role of Anti-IL-1 Blockade in the Treatment of Monogenic and Multi-Factorial Autoinflammatory Diseases
- (2013) Silvia Federici et al. Frontiers in Immunology
- Cytokine mediated tissue fibrosis
- (2012) Lee A. Borthwick et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice
- (2012) Jan Petrasek et al. JOURNAL OF CLINICAL INVESTIGATION
- Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein Kinases
- (2011) M. Cargnello et al. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
- Toll-Like Receptor 9 Promotes Steatohepatitis by Induction of Interleukin-1β in Mice
- (2010) Kouichi Miura et al. GASTROENTEROLOGY
- Contribution of hepatic stellate cells and matrix metalloproteinase 9 in acute liver failure
- (2010) Chunli Yan et al. LIVER INTERNATIONAL
- Canakinumab
- (2010) Eugen Dhimolea mAbs
- Interleukin-1 participates in the progression from liver injury to fibrosis
- (2009) Roben G. Gieling et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Inflammatory arthritis in caspase 1 geneâdeficient mice: Contribution of proteinase 3 to caspase 1âindependent production of bioactive interleukin-1β
- (2009) Leo A. B. Joosten et al. ARTHRITIS AND RHEUMATISM
- Mechanisms of interleukin-1β release
- (2009) Claudia Eder IMMUNOBIOLOGY
- The basics of epithelial-mesenchymal transition
- (2009) Raghu Kalluri et al. JOURNAL OF CLINICAL INVESTIGATION
- IL-1RI deficiency ameliorates early experimental renal interstitial fibrosis
- (2009) Lynelle K. Jones et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- The human anti-IL-1β monoclonal antibody ACZ885 is effective in joint inflammation models in mice and in a proof-of-concept study in patients with rheumatoid arthritis
- (2008) Rieke Alten et al. ARTHRITIS RESEARCH & THERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More